---
document_datetime: 2023-09-21 19:51:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/aerivio-spiromax-epar-all-authorised-presentations_en.pdf
document_name: aerivio-spiromax-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.77871
conversion_datetime: 2025-12-21 18:25:00.695035
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | Invented name    | Strength       | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size                 |
|------------------|------------------|----------------|-----------------------|---------------------------|-----------------------|---------------------------|
| EU/1/16/1122/001 | Aerivio Spiromax | 50 µg / 500 µg | Inhalation powder     | Inhalation use            | inhaler (ABS/PE/PP)   | 1 inhaler (60 doses)      |
| EU/1/16/1122/002 | Aerivio Spiromax | 50 µg / 500 µg | Inhalation powder     | Inhalation use            | inhaler (ABS/PE/PP)   | 3 inhalers (3 x 60 doses) |

<!-- image -->